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Abstract
Background: Vitamin D deficiency is an important health concern because it is related to several comorbidities and
mortality. However, its relationship with the risk of hematuria remains undetermined in the general population. In
this study, we analyzed the association between vitamin D deficiency and hematuria.
Methods: We conducted cross-sectional analysis using data of participants from the Korean National Health and
Nutrition Examination Survey (KNHANES) 2010–2014. A total of 20,240 participants, aged ≥18 years old, were
analyzed. Serum 25-hydroxyvitamin D (25(OH)D) levels were measured in a central laboratory and hematuria was
defined as ≥1+ on a dipstick test. Multivariate logistic regression was conducted to calculate the odds ratio (OR) of
hematuria risk according to serum 25(OH)D quartiles, after adjusting several covariates.
Results: A total 3144 (15.5%) participants had hematuria. The mean 25(OH)D level was 17.4 ± 6.2 ng/mL (median,
16.6 ng/mL (interquartile range, 13.1–20.8 ng/mL)). The 3rd and 4th quartiles had a higher risk of hematuria than
the 1st quartile, with adjusted ORs 1.26 (1.114–1.415) and 1.40 (1.240–1.572) in the 3rd and 4th quartiles,
respectively. However, this relationship was only significant in women, not in men. When stratified analyses were
conducted according to menopausal status, there was a significant increase of hematuria risk according to quartiles
in postmenopausal but not in premenopausal women.
Conclusion: We found that vitamin D deficiency is correlated with hematuria in women, particularly after
menopause. Further interventional studies are warranted to address whether correcting vitamin D deficiency can
lower the risk of hematuria.
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Background
Vitamin D has receptors that are expressed in many
nucleated cells and controls the expression of various
human genes [1]. Vitamin D deficiency aggravates bone
diseases, leading to osteoporosis, and increases the risk
of falls and fractures [2, 3]. In addition to its relationship
with skeletal health, the association of vitamin D defi-
ciency and various other diseases such as hypertension
[4], cardiovascular disease [5–7], cancer [8–11], infec-
tious disease, and metabolic disease [12] have also re-
ceived attention. Vitamin D deficiency is a global health
problem related to poor nutrition [2], and the prevalence
of vitamin D deficiency is relatively high worldwide. Ac-
cording to data from the National Health and Nutrition
Examination Survey of the United States, 10–40% of the
population is deficient in vitamin D [13]. The prevalence
of vitamin D deficiency is even higher among Asians
than in the United States [2]. According to a Korean re-
port, 47.3% of males and 64.5% of females are deficient
in vitamin D [14]. Correcting vitamin D deficiency is es-
sential to preventing several related diseases and im-
proving global human health.
Hematuria is the presence of red blood cells in the urine.
The prevalence of hematuria ranges from 0.2 to 16.1% in
the general population [15, 16]. In one study, 6.2% of
Korean participants who underwent health screening had
asymptomatic hematuria [17]. Hematuria is frequently the
result of nonglomerular causes, such as an infection or
stone in the urinary tract. Additionally, hematuria can be a
manifestation of glomerular kidney disease or polycystic
kidney disease and is known to be a risk factor of progres-
sive kidney dysfunction and end-stage renal disease [18].
Various urinary tract neoplasms originating in the bladder,
prostate, ureter, and kidney may manifest as microscopic
and gross hematuria [19]. Therefore, hematuria is an
important sign of disease and its cause should be evaluated
to prevent further disease progression.
Despite the clinical importance of vitamin D deficiency
and hematuria, no studies have been conducted to inves-
tigate their correlation in the general population. Correl-
ation between proteinuria and vitamin D deficiency has
been evaluated in various studies [20, 21]. However, the
association between vitamin D status and the hematuria,
another important parameter of kidney disease other
than proteinuria, has not been evaluated yet. Further-
more, there are accumulating evidence that vitamin D
deficiency contributes to pathologic conditions that can
be presented as hematuria such as urinary stone [22],
infection [23] and malignancy [24]. The present study is
the first to examine this correlation using data of a
nationwide population-based survey, stratified by sex
and menopause status as these parameters are known to




This was a nationwide population-based cross-sectional
study using data of the Korean National Health and
Nutrition Examination Survey (KNHANES), conducted
by the Korean Centers for Disease Control and Preven-
tion in South Korea. We used data of both the
KNHANES V (2010–2012) and KNHANES VI (2013–
2015) surveys conducted in South Korea. Of a total
41,102 participants, we included 20,295 participants,
aged ≥18 years, for whom results of both urinalysis and
serum 25-hydroxyvitamin D (25(OH)D) levels were
available. After excluding 55 women who were menstru-
ating at the time of examination, a total 20,240 partici-
pants (49.2% of the total population surveyed) were
analyzed in the present study.
Study variables
Demographic variables were collected during health in-
terviews, including age, sex, menopause status, alcohol
consumption, and smoking status. Alcohol consumption
was defined as drinking once or more per month.
Smoking status was classified as nonsmoker, former
smoker, or current smoker. Information was also ob-
tained about underlying comorbidities including hyper-
tension, diabetes, and cardiovascular disease. Weight
(kg) and height (cm) were measured with participants
wearing a gown and no shoes. Body mass index was
calculated as weight (kg) divided by square of height
(m2). Body mass index < 18.5 kg/m2, 18.5–22.9 kg/m2,
23.0–24.9 kg/m2, and ≥ 25.0 kg/m2 were defined as
underweight, normal weight, overweight, and pre-obese
and obesity, respectively [27]. Blood pressure was mea-
sured with patients at rest. Participants were defined as
having hypertension with systolic blood pressure ≥ 140
mmHg, diastolic blood pressure ≥ 90mmHg, or a history
of taking blood pressure lowering agents. Fasting blood
samples were collected during health examination
surveys. The samples were refrigerated and transported
to the designated central laboratory (NeoDin Medical
Institute, Seoul, Korea). Fasting glucose levels were mea-
sured using the enzymatic UV (hexokinase) method with
a Hitachi 7600 automated analyzer (Hitachi, Tokyo,
Japan). Participants with diabetes were defined as those
with a fasting glucose level of ≥126 mg/dL or taking
diabetes medication or insulin. A fasting glucose level
between 100 mg/dL and 125 mg/dL was defined as
impaired fasting glucose status. Hypercholesterolemia
was defined in participants with total fasting cholesterol
level ≥ 240 mg/dL or taking cholesterol lowering agents.
Total cholesterol was measured using an enzymatic
method and a Hitachi 7600–210 analyzer (Hitachi).
Serum hemoglobin levels were measured using the SLS
hemoglobin detection method with a XE-2100D analyzer
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(Sysmex, Tokyo, Japan), and anemia was defined as a
hemoglobin level < 13 g/dL for men and < 12 g/dL for
women. Serum creatinine levels were measured by the
Jaffe rate-blanked and compensated method using the
Hitachi 7600–210 analyzer. The estimated glomerular
filtration rate was calculated using the Chronic Kidney
Disease Epidemiology Collaboration equation [28]. Serum
25(OH)D levels were measured using radioimmunoassay
with a 1470 WIZARD gamma counter (PerkinElmer
Finland Oy, Finland) with a 25-hydroxyvitamin D 125I
RIA kit (DiaSorin Corp., Stillwater Minnesota, USA). We
defined serum 25(OH)D inadequacy as serum 25(OH)D
level < 30 ng/mL and deficiency as < 20 ng/mL [29].
Random early morning urine samples were collected,
whenever possible. All urine samples were refrigerated
and transported to the central laboratory (NeoDin
Medical Institute). The results of dipstick tests were
scored from negative to + 4. Hematuria, proteinuria, and
glycosuria were defined as ≥1+ on a dipstick test.
Statistical analysis
IBM SPSS version 20.0 (IBM Corp., Armonk, NY, USA)
was used for all analyses. Continuous variables including
age, height, body mass index, blood pressure, fasting
blood glucose, serum hemoglobin, and estimated glom-
erular filtration rate showed normal distributions and
were presented as mean value and standard deviation.
However, serum 25(OH)D levels showed a non-normal
distribution, and were therefore expressed as median
value and interquartile range. A logistic regression ana-
lysis was used to calculate odds ratios (ORs) and 95%
confidence intervals for the risk of hematuria. Multivariate
logistic regression was conducted after adjusting all covar-
iates, such as comorbidities and laboratory findings. A
nonlinear relationship between 25(OH)D and risk of
hematuria was examined using the cubic spline regression
model. A P value < 0.05 was considered significant.
In this study, subsequent analyses according to sex
and menopausal status were conducted to see the risk
difference in hematuria. Predicted probability plot of
hematuria was drawn according to sex using cubic spine
regression model and multivariate logistic regression




Of a total 20,240 study participants, 10,847 (53.6%) were
women and 5388 (26.6%) were identified as postmeno-
pausal. The mean participant age was 49 ± 16.3 years and
mean estimated glomerular filtration rate was 88 ± 17.4
mL/min/1.73 m2. There were a total 3144 (15.5%) partic-
ipants with hematuria, and the mean serum 25(OH)D
level was 17.4 ± 6.2 ng/mL (median 16.6 ng/mL (13.1–
20.8 ng/mL)). Among the total participants, 19,427
(96.0%) had serum 25(OH)D levels < 30 ng/mL, and
14,373 (71.0%) had levels below 20 ng/mL. Blood pres-
sure corresponded to prehypertension in 4845 (23.9%)
participants, and 6137 (30.3%) participants had hyper-
tension. A total 3751 (18.5%) patients were diagnosed as
having impaired fasting glucose and 1969 (9.7%) patients
had diabetes mellitus. A total 503 (2.5%) participants
showed glycosuria and 228 (1.1%) proteinuria. Other
demographic and laboratory findings are shown in
Table 1.
Factors associated with hematuria
A univariate logistic regression analysis was conducted
to examine the association between the covariates and
hematuria (Table 2). Age > 30 years, female sex and espe-
cially postmenopausal status, hypertension, hypercholes-
terolemia, anemia, 30–60 mL/min/1.73 m2 of estimated
glomerular filtration rate, and proteinuria were associ-
ated with risk of hematuria. Drinking alcohol, former or
current smoker, diabetes mellitus, and glycosuria showed
a negative relationship with hematuria. These covariates
were adjusted in subsequent multivariate regression
analyses.
Association between serum vitamin D level and
hematuria
As shown in Fig. 1, the prevalence of hematuria in-
creased in proportion to lower 25(OH)D levels. A total
13.8% of participants in the 4th quartile of serum
25(OH)D (≥ 20.8 ng/mL) showed hematuria whereas the
prevalence of hematuria increased from the 3rd to 1st
quartiles, as follows: 14.6% in the 3rd quartile (16.4–20.7
ng/mL), 16.3% in the 2nd quartile (13.0–16.3 ng/mL), and
17.7% in the 1st quartile (< 13.0 ng/mL) (Ptrend < 0.001).
In univariate analysis, the 3rd and 4th quartiles showed a
higher risk of hematuria than the 1st quartile: OR 1.20
(1.072–1.336) and OR 1.35 (1.210–1.501) in the 3rd and
the 4th quartiles, respectively. When comparing the
groups with 25(OH)D levels < 30 ng/mL and ≥ 30 ng/mL,
the lower group showed a higher OR of hematuria (1.33
(1.071–1.639)) than the higher group (P = 0.010). When
vitamin D deficiency was defined as < 20 ng/mL, the
deficient group showed a higher OR of hematuria (1.20
(1.102–1.309)) than the higher group (P < 0.001). These
differences were also significant despite adjusting for
multiple covariates which were significant in the univari-
ate analysis (Table 3).
Subgroup analysis according to sex and menopausal status
Because the risk of several diseases differs according to
sex and menopausal status [10, 25, 30], subsequent
analyses were conducted after stratification by these
factors. Figure 2 shows the predicted probability plot of
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hematuria according to sex. The linear relationship
seemed to be more dominant in women than in men.
When multiple covariates were adjusted, the low
25(OH)D groups (inadequate or deficient) showed
higher ORs of hematuria than the high 25(OH)D groups
for both sexes. According to menopausal status, no rela-
tionship was found among premenopausal women, how-
ever, the relationship was significant in postmenopausal
women (Table 4).
Discussion
Vitamin D deficiency and hematuria are important
public health problems with high incidence in the gen-
eral population, and both may be related to more severe
diseases. However, there have been no studies conducted
to investigate the relationship between vitamin D
deficiency and hematuria. We addressed this question in
the present study, using data of the KNHANES nation-
wide population-based survey. The risk of hematuria
Table 1 Baseline characteristics of the study population
Total
(n = 20,240)
Normal (≥ 30 ng/mL)
(n = 813)
Inadequacy (< 30 ng/mL)
(n = 19,427)
P
Age (years) 49.4 ± 16.3 57.9 ± 14.1 49.1 ± 16.3 < 0.001
Female (%) 53.6 46.6 53.9 < 0.001
Post-menopausal women (%) 26.6 26.2 36.9 < 0.001
Body mass index (kg/m2) 23.7 ± 3.4 23.4 ± 3.1 23.7 ± 3.4 0. 006
Obesity classification (%) 0.026
Under weight 4.1 3.4 4.1
Normal weight 39.1 41.4 39.0
Over weight 24.0 26.7 23.9
Obesity 32.8 28.4 33.0
Alcohol (%) 72.8 68.2 73.0 0.003
Smoking (%) 0.010
None 57.9 53.0 58.1
Former smoker 20.5 24.1 20.3
Current smoker 21.6 22.9 21.6
Systolic blood pressure (mmHg) 119.6 ± 17.1 123.3 ± 17.5 119.4 ± 17.1 < 0.001
Diastolic blood pressure (mmHg) 76.2 ± 10.5 76.9 ± 10.3 76.2 ± 10.5 0.066
Blood pressure status (%) < 0.001
Prehypertension 25 27.3 24.9
Hypertension 31.7 41.2 31.3
Fasting blood glucose (mg/dL) 98.1 ± 21.7 99.7 ± 19.6 98.0 ± 21.8 0.016
Impaired glucose tolerance (%) < 0.001
Impaired fasting glucose 19.7 19.6 22.7
Diabetes mellitus 10.4 10.2 13.4
Cardiovascular disease (%) 2.6 3.7 2.5 0.063
Hypercholesterolemia (%) 15.0 17.3 14.9 0.071
Hemoglobin (g/dL) 14.1 ± 1.6 14.1 ± 1.5 14.1 ± 1.6 0.511
Anemia (%) 8.0 9.2 7.9 0.229
Estimated GFR (mL/min/1.73 m2) 94.7 ± 17.2 83.7 ± 17.7 88.6 ± 17.3 < 0.001
Estimated GFR under 60 mL/min/1.73 m2 (%) 3.7 7.3 3.6 < 0.001
Serum 25(OH)D (ng/mL)a 16.6 (13.1–20.8) 33.1 (31.4–35.7) 16.3 (12.9–20.2) < 0.001
Glycosuria (%) 2.5 2.1 2.5 0.534
Proteinuria (%) 1.1 0.6 1.1 0.215
Hematuria (%) 15.5 12.3 15.7 0.011
GFR glomerular filtration rate, 25(OH)D 25-hydroxyvitamin D
aData are expressed as the median (interquartile range) when the data distribution was skewed
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increased with decreased serum 25(OH)D levels. This
increasing risk of hematuria was seen for both vitamin D
inadequacy and deficiency, particularly in postmeno-
pausal women. Nevertheless, this relationship was only
significant after menopause in women.
Previous studies have reported the correlations be-
tween vitamin D deficiency and various diseases wherein
hematuria is one of the disease signs [22, 24, 31, 32]. Be-
cause vitamin D enhances the absorption of calcium
from the intestine and stimulates bone absorption to
physiologically increase serum calcium levels [2], it is
plausible that vitamin D might increase the risk of urin-
ary stones, thereby leading to hematuria. However, the
evidence is insufficient owing to the observational nature
of conducted studies [33, 34], and there are contradict-
ory reports in which the risk of calcium-based urinary
stones is higher with vitamin D deficiency [22, 35].
Vitamin D has an important role in the immune sys-
tem via controlling the expression of many immunologic
factors. As a result, an association between vitamin D
deficiency and risk of urinary tract infection has been
reported [23, 36, 37]. One study showed that premeno-
pausal women had a 4-fold increased risk of recurrent
urinary tract infection with serum 25(OH)D levels < 15
ng/mL [23], and the correlation between vitamin D defi-
ciency and urinary tract infection has been documented
in children and kidney transplant recipients [36, 37].
Because hematuria is one sign of urinary tract infection,
the present results may be attributable to the above
mechanism.
Vitamin D deficiency is related to the progression
of kidney disease via both direct and indirect effects.
End-stage renal disease and proteinuria are more
prevalent in individuals who are deficient in vitamin
D [20, 21, 38]. In a cross-sectional analysis of patients
with polycystic kidney disease, kidney volumes were
larger in individuals with vitamin D deficiency [31].
Table 2 Odds ratios for hematuria of baseline variables
Variables OR (95% CI) P
Age (years)
< 20 1 (reference)
20–29 1.14 (0.780–1.651) 0.508
30–39 1.51 (1.054–2.166) 0.025
40–49 2.21 (1.550–3.162) < 0.001
50–59 2.53 (1.776–3.605) < 0.001
60–69 2.62 (1.835–3.732) < 0.001
≥ 70 3.72 (2.604–5.314) < 0.001
Gender
Male 1 (reference)
Female 2.60 (2.390–2.825) < 0.001
Menopausal status
Pre-menopause 1 (reference)
Post-menopause 3.06 (2.782–3.356) < 0.001
Body mass index (kg/m2)
< 18.5 1 (reference)
18.5–22.9 1.04 (0.857–1.271) 0.673
23.0–24.9 0.94 (0.769–1.157) 0.573
≥ 25.0 0.94 (0.771–1.149) 0.551
Alcohol
(−) 1 (reference)
(+) 0.68 (0.629–0.742) < 0.001
Smoking
None 1 (reference)
Former smoker 0.53 (0.470–0.587) < 0.001
Current smoker 0.62 (0.561–0.689) < 0.001
Hypertension
None 1 (reference)
Prehypertension 0.91 (0.910–1.111) 0.913
Hypertension 1.20 (1.096–1.311) < 0.001
Diabetes mellitus
None 1 (reference)
Impaired fasting glucose 1.10 (0.996–1.209) 0.061
Diabetes mellitus 0.67 (0.579–0.777) < 0.001
Cardiovascular disease
(−) 1 (reference)
(+) 1.19 (0.944–1.499) 0.141
Hypercholesterolemia
(−) 1 (reference)
(+) 1.13 (1.020–1.261) 0.020
Anemia
(−) 1 (reference)
(+) 1.57 (1.384–1.778) < 0.001
Table 2 Odds ratios for hematuria of baseline variables
(Continued)
Variables OR (95% CI) P
Estimated GFR (mL/min/1.73 m2)
≥ 60.0 1 (reference)
30.0–59.9 1.35 (1.117–1.627) 0.002
< 30.0 1.55 (0.739–3.248) 0.247
Glycosuria
(−) or trace 1 (reference)
≥ 1+ 0.62 (0.465–0.829) < 0.001
Proteinuria
(−) or trace 1 (reference)
≥ 1+ 5.12 (3.940–6.663) < 0.001
OR odds ratio, CI confidence interval, GFR glomerular filtration rate
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Animal studies have showed that low vitamin D levels
are correlated with podocyte loss and development of
glomerulosclerosis [39]. An acute kidney injury model
demonstrated that vitamin D deficiency induces tubuloin-
terstitial damage and fibrosis and diminishes renal vascu-
larity, which finally leads to chronic change [40]. Vitamin
D deficiency is additionally linked to activation of the
renin–angiotensin system, promoting endothelial damage
and the progression of diabetes [41].
Vitamin D deficiency is related to high incidence and
aggressiveness of various malignancies [8, 10, 42] that
have been documented in the urological system, such as
renal cell carcinoma [24] and bladder cancer [32]. Vari-
ous possible antineoplastic mechanisms of active vitamin
D have been suggested. Active vitamin D can regulate
transcription of anticancer target genes that induce
apoptosis and differentiation and inhibit proliferation,
inflammation, angiogenesis, invasion, and metastasis of
cancer cells [43]. Vitamin D regulates signaling pathways
such as the Wnt/β-catenin, estrogen receptor, and
androgen receptor in the colon, breast, and prostate,
respectively, which subsequently affect the growth of
cancer in each tissue [43]. Additionally, microRNA can
mediate the antineoplastic functions of vitamin D [43].
Collectively, the above mechanisms support the present
study results.
The subsequent analysis showed that the correlation
between hematuria and vitamin D deficiency was
predominant in postmenopausal women but not in pre-
menopausal women. The different effects of vitamin D
deficiency according to menopausal status have been
previously reported [10, 26, 30], but the mechanisms
have not been clearly determined. Vitamin D is one of
the steroid hormones and it is closely related to sex
Fig. 1 Prevalence of hematuria according to serum 25-hydroxyvitamin D level
Table 3 Odds ratios for hematuria according to serum 25-hydroxyvitamin D levels
Groups Univariate Multivariatea
OR (95% CI) P OR (95% CI) P
Quartiles
1st quartile (≥ 20.8 ng/mL) 1 (reference) 1 (reference)
2nd quartile (16.4–20.7 ng/mL) 1.07 (0.960–1.196) 0.219 1.14 (1.014–1.284) 0.028
3rd quartile (13.0–16.3 ng/mL) 1.20 (1.072–1.336) 0.001 1.26 (1.114–1.415) < 0.001
4th quartile (< 13.0 ng/mL) 1.35 (1.210–1.501) < 0.001 1.40 (1.240–1.572) < 0.001
Vitamin D inadequacy
Normal (≥ 30 ng/mL) 1 (reference) 1 (reference)
Inadequacy (< 30 ng/mL) 1.33 (1.071–1.639) 0.010 1.44 (1.150–1.800) 0.001
Vitamin D deficiency
Normal (≥ 20 ng/mL) 1 (reference) 1 (reference)
Deficiency (< 20 ng/mL) 1.20 (1.102–1.309) < 0.001 1.25 (1.137–1.373) < 0.001
aAdjusted for age, gender, alcohol, smoking, diabetes, hypertension, hypercholesterolemia, anemia, chronic kidney disease, glycosuria, and proteinuria
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hormones such as estrogen and testosterone, levels of
which may vary with menopausal status, thereby affect-
ing the relationship with disease risk. Further fundamen-
tal studies are needed to confirm the different effects of
vitamin D on hematuria according to menopausal status.
This study has several limitations. We used one-time
spot urine samples and defined presence of hematuria as
≥1+ on a dipstick test. Owing to the possibility of a false
positive or false negative on a single test, this approach
might have resulted in incorrectly grouped participants.
Furthermore, positive dipstick test does not always mean
hematuria but may reflect the presence of heme pigment
which can be positive in the condition of red blood cell
lysis or myositis. Accordingly, using the dipstick test alone
may result in false-positivity. Another major limitation is
that, we could not obtain information on the cause of
hematuria and other laboratory results (e.g., calcium,
phosphorous, parathyroid hormone and 1,25 OH Vitamin
D level) which may have an interaction in the relationship
results. Because the study design was cross-sectional,
there is a lack of information about whether the effects of
vitamin D deficiency on hematuria eventually lead to
occurrence of disease and alter patient prognosis.
Our study is the first to address the correlation
between vitamin D deficiency and hematuria risk using a
large nationwide cohort. Despite adjusting for several
covariates that might affect the presence of hematuria,
participants who had inadequate or deficient vitamin D
levels had a higher risk of hematuria than participants
with normal levels. Further physiological and epidemio-
logical studies are required to find out the underlying
mechanisms and whether the supplemental vitamin D
would be beneficial in various diseases related to
hematuria.
Fig. 2 Nonlinear relationship between serum 25-hydroxyvitamin D and risk of hematuria in male (a) and female (b) subjects
Table 4 Risk of hematuria after stratification by sex and menopausal status
Male Female Pre-menopausal females Post-menopausal females
OR (95% CI)a P OR (95% CI)a P OR (95% CI)a P OR (95% CI)a P
Quartiles
1st quartile 1 (reference) 1 (reference) 1 (reference) 1 (reference)
2nd quartile 1.23 (1.014–1.498) 0.036 1.09 (0.941–1.266) 0.247 0.94 (0.726–1.225) 0.659 1.18 (0.986–1.418) 0.071
3rd quartile 1.38 (1.121–1.706) 0.002 1.20 (1.035–1.386) 0.015 1.12 (0.875–1.433) 0.369 1.19 (0.991–1.437) 0.062
4th quartile 1.35 (1.080–1.695) 0.007 1.38 (1.200–1.593) < 0.001 1.15 (0.905–1.460) 0.253 1.58 (1.320–1.892) < 0.001
Vitamin D inadequacy
Normal 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Inadequacy 1.32 (0.915–1.889) 0.139 1.50 (1.127–1.989) 0.005 1.10 (0.597–2.019) 0.764 1.62 (1.177–2.237) 0.003
Vitamin D deficiency
Normal 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Deficiency 1.26 (1.077–1.481) 0.004 1.24 (1.101–1.393) < 0.001 1.15 (0.933–1.419) 0.188 1.29 (1.123–1.491) < 0.001
OR odds ratio, CI confidence interval
aAdjusted for age, alcohol, smoking, diabetes, hypertension, hypercholesterolemia, anemia, chronic kidney disease, glycosuria, and proteinuria
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Conclusions
Vitamin D deficiency and hematuria are both common
health problem in general population. The association
between vitamin D deficiency and hematuria was no-
ticed in this study, particularly in postmenopausal
women. Patients with vitamin D deficiency should be
concern about the risk of hematuria and related disease.
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